Novo Nordisk A/S ( NVO) - Stock Earnings
NVO Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 4.2 billion USD | 12.4 billion USD |
| 2026Q1 | 7.4 billion USD | 14.9 billion USD |
| 2026Q2 | 3.2 billion USD | 12.0 billion USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
NVO Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 12.4 billion USD | 34.4 billion USD |
| 2024 | 14.1 billion USD | 40.5 billion USD |
| 2025 | 16.1 billion USD | 48.6 billion USD |
| 2026 Est. | — | — |
NVO
Price: $46.93
Dividend Yield: 3.80%
Forward Dividend Yield: 2.48%
Payout Ratio: 24.32%
Dividend Per Share: 1.16 USD
Earnings Per Share: 4.09 USD
P/E Ratio: 11.67
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: Denmark
Volume: 1.1 million
Ebitda: 1.9 billionMarket Capitalization: 209.1 billion
Average Dividend Frequency: 2
Years Paying Dividends: 45
DGR3: 29.57%
DGR5: 22.96%
DGR10: 20.32%
DGR20: 22.69%